Clinical trial
AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled…
NCT00359112 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00359112 |
|---|---|
| Title | AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes |
| Official title | A Randomised, Multi-Centre, Phase IV, Double-Blind, Parallel Group Study Comparing the Effects of 52 Weeks Administration of AVANDAMET and Metformin Plus Sulphonylurea on Change in HbA1c From Baseline in Overweight Type 2 Diabetics Poorly Controlled on Metformin. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Insulin-Dependent Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | metformin, sulphonylurea, Avandamet |
| Enrollment | 544 |
| Start date | Feb 1, 2004 |
| First posted | Aug 1, 2006 |
| Last update posted | May 18, 2009 |
| Countries | Belgium, France, Germany, Ireland, Italy, Lithuania, Mexico, Netherlands, Spain, Switzerland, United Kingdom |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: